INTRODUCTION
In C. elegans one-cell embryos, polarity along the anteroposterior axis is marked by the asymmetric distribution of PAR proteins, which form two distinct domains. The anterior domain is defined by a conserved complex consisting of PAR-3, PAR-6 and atypical protein kinase C (PKC-3) (Cuenca et al., 2003; Etemad-Moghadam et al., 1995; Hung and Kemphues, 1999; Tabuse et al., 1998; Watts et al., 1996) . The posterior domain is defined by PAR-1 and PAR-2 Cuenca et al., 2003; Guo and Kemphues, 1995) . The establishment of the anterior and posterior PAR domains is a dynamic process. Following fertilization, the anterior and posteriorcell migration depend largely on the acto-myosin cytoskeleton. RhoA is required for the assembly of actin filaments and myosin II into contractile filaments that provide the mechanical force for cortical contractions, motility and cytokinesis (reviewed by EtienneManneville and Hall, 2002; Glotzer, 2005) . Thus, both RhoA and Cdc42 are essential for many types of cell polarity. However, it remains unclear how their functions are coordinated in cell polarity.
CDC-42 and RHO-1 play essential roles in the C. elegans one-cell embryo. Previous studies have shown that after depletion of CDC-42, PAR-2 was found uniformly at the cortex and PAR-6 was either anteriorly enriched, as in wild type, or scattered throughout the entire cortex at the two-cell stage (Gotta et al., 2001; Kay and Hunter et al., 2001) . As CDC-42 was shown to interact with PAR-6 in many systems, including C. elegans (Gotta et al., 2001; Hutterer et al., 2004; Joberty et al., 2000; Johansson et al., 2000; Lin et al., 2000; Qiu et al., 2000) , it seemed likely that CDC-42 would act through PAR-6 to regulate polarity. These studies demonstrated the involvement of CDC-42 in C. elegans polarity, although which specific process in polarity establishment is affected by CDC-42 remains unclear.
RHO-1 was shown to function in cytokinesis (Jantsch-Plunger et al., 2000) , presumably by regulating acto-myosin activity. It has been demonstrated that polarity establishment in C. elegans embryos requires the acto-myosin cytoskeleton. Embryos treated with actindepolymerizing drugs or depleted of myosin II subunits, or the actin nucleators profilin or formin, do not establish polarity: PAR-2 is unable to localize correctly to the cortex and PAR-3/PAR-6 remain uniformly distributed around the entire cortex (Cuenca et al., 2003; Guo and and Kemphues, 1996; Severson and Bowerman, 2003; Shelton et al., 1999) (S.S. and A.A.H., unpublished) . Thus, in C. elegans embryos, RHO-1 may be involved in polarity establishment, possibly through regulation of the acto-myosin cytoskeleton, although this remains to be tested.
Here, we investigate the roles of CDC-42 and RHO-1 in polarity establishment in C. elegans embryos and examine the interaction between these two signaling pathways in cell polarity. Our data suggest that RHO-1 and CDC-42 have separable functions in polarity establishment. We show that RHO-1 activity is required for actomyosin contractility and organization of the NMY-2 meshwork, which, in turn, is essential for localizing CDC-42 to the anterior half of the embryo. CDC-42, in turn, is required to stabilize the actomyosin network and for localizing PAR-6 in the anterior. In addition, CDC-42 removes PAR-2 from the cortex during meiosis. We have found that during polarity establishment the roles of RHO-1 and CDC-42 are interdependent, and appear to be coordinated, in part, through the acto-myosin contractile network in C. elegans one-cell embryos.
MATERIALS AND METHODS

Worm strains
Worms were handled as described (Brenner, 1974) . The following strains were used: N2 (wild type), JH1380 (GFP-PAR-2), TH25 (GFP-PAR-6), JJ1473 (NMY-2-GFP), TH71 (NMY-2-GFP;GFP-PAR-2), TH72 (YFP-CDC-42), ]. The TH71 strain was constructed by crossing JH1380 to JJ1473 and progeny were selected that expressed both GFPs. TH72 was crossed to KK571 to analyze YFP-CDC-42 localization in a par-3(it71) background. The cdc-42 coding sequence (R07G3.1) was identified using the WormBase web site (release WS155; http://www.wormbase.org) and was amplified by PCR from wild-type strain N2 genomic DNA using the primers 5Ј-ggccactagtggaATGCAGACG-ATCAAGTGCGTC-3Ј and 5Ј-ggcccccgggCTAGAGAATATTGCACTT-CTTCT-3Ј, containing SpeI or XmaI sites (bold). The N-terminal YFPfusion was generated in pTH-YFP(N) (a modified version of the pAZ132 plasmid, a gift from Andrei Pozniakovsky, Max Planck Institute of Cell Biology and Genetics, Dresden), expressing YFP under the control of the pie-1 promoter. Transgenic worms were created by high-pressure ballistic bombardment (BioRad) of DP38 unc-119(ed3) homozygotes, as described previously (Praitis et al., 2001) .
The YFP-CDC-42 transgene was tested for functionality by using doublestranded RNA against the 3ЈUTR of cdc-42 to deplete endogenous CDC-42 in wild-type N2 and YFP-CDC-42 worms. Injected worms were then assayed for embryonic hatching. The YFP-CDC-42 fusion uses the pie-1 3ЈUTR, and therefore was not targeted by the cdc-42 3ЈUTR doublestranded RNA. To test whether RNAi against the 3ЈUTR of cdc-42 gives the same phenotype as cdc-42(RNAi), cdc-42 3ЈUTR RNA was injected into GFP-PAR-2. We found that PAR-2 was uniformly localized, as in cdc-42(RNAi) embryos (n=7, data not shown). To determine embryonic hatching, injected worms were placed on individual plates for 56 hours at 25°C and allowed to lay eggs for 5 hours at 25°C. These embryos were checked for hatching 48 hours later. The progeny of N2 worms injected with cdc-42 3ЈUTR RNA showed 0% embryonic hatching (21 worms, 193 embryos), whereas the progeny of injected YFP-CDC-42 worms (19 worms, 178 embryos) showed 96.2% hatching, indicating that the YFP-CDC-42 is functional.
RNA-mediated interference
RNAi experiments were performed as described (Oegema et al., 2001) . Primers used to amplify regions from N2 genomic DNA are listed in Table  1 . Worms were incubated depending on the individual double-stranded RNA for 10-26 hours at 25°C after injection. Cdc-42(RNAi);rho-1(RNAi) was performed by co-injection of both RNAs, combined with feeding of cdc-42(RNAi) (Timmons and Fire, 1998) . Cdc-42(RNAi);spd-2(RNAi) was performed by co-injection of both RNAs, combined with feeding of cdc-42(RNAi) and spd-2(RNAi). Worms were placed on feeding plates after injection and maintained at 25°C for 22-48 hours.
One general complication of our analyses was that CDC-42, as well as RHO-1 and ECT-2, is essential for oocyte formation in C. elegans. Complete depletion by RNAi leads to sterility and therefore we could not analyze polarity under such conditions. We conducted many analyses to determine the maximum depletions that would still yield embryos. In realtime studies, we concentrated our analysis solely on embryos that had cleaved symmetrically after cdc-42(RNAi) or failed to undergo cytokinesis after rho-1(RNAi) or ect-2(RNAi). For immunofluorescence experiments, we performed RNAi of CDC-42 for 48 hours at 25°C. Under these conditions, in eight out of 10 embryos, PAR-6 did not localize to the cortex. Previous experiments showed some PAR-6 on the cortex after cdc-42(RNAi) (Gotta et al., 2001; Kay and Hunter, 2001 ). The discrepancy between the different results is probably due to a difference in RNAi penetrance, as Gotta et al. (Gotta et al., 2001 ) used different RNAi
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Development 133 (18) conditions. After RNAi of CDC-42 for 26 hours at 25°C, we also found some PAR-6 on the anterior cortex, but at very reduced levels (data not shown).
Time-lapse microscopy
Worms were shifted to 25°C before recording. Embryos were dissected and mounted in a solution containing 0.1 M NaCl and 4% sucrose, with and without 2% agarose. GFP, YFP and differential interference contrast (DIC) recordings were acquired at 10-15 second intervals (exposure time 400 mseconds, 2ϫ2 binning) with a Hamamatsu Orca ER 12 bit digital camera mounted on a spinning disk confocal microscope (Zeiss Axioplan using a 63ϫ 1.4 NA PlanApochromat objective and Yokogawa disk head). Illumination was via a 488 nm Argon ion laser (Melles Griot). Movies acquired for Fig. 2 were done on a wide-field microscope (Zeiss Axioplan II using a 63ϫ 1.4 NA PlanApochromat objective equipped with a Hamamatsu Orca ER 12 bit digital camera).
Image processing was done with MetaView Software (Universal Imaging Corporation).
Immunofluorescence
Immunofluorescence was performed as described (Gönczy et al., 1999) . For the PAR-2 immunostaining, the GFP-PAR-2 strain (JH1380) was used. A sheep polyclonal antibody to GFP (1:1000; a gift from Francis Barr, MaxPlanck-Institute of Biochemistry, Martinsried, Germany) was used to visualize PAR-2. DM1␣ (1:300, Sigma) and SPD-2, 1:5000, (Pelletier et al., 2004) were used to detect microtubules and centrosomes. PAR-6 was stained with a C-terminal peptide (amino acid 291-308) anti-PAR-6 antibody. The antibodies were visualized with TR-and Cy5-conjugated antibodies (Jackson Immunochemicals), and with a donkey anti-sheep antibody coupled to Alexa 488 (Molecular Probes). Imaging was performed on a DeltaVision microscope and stacks were deconvolved as described (Oegema et al., 2001) . SPD-2 and DNA images are projections of z-sections representing the entire cell. PAR-2, PAR-6 and Tubulin images are projections of four to 10 z-sections.
Contractility tracking
The ruffle kymographs were performed as described (Cowan and Hyman, 2004b) . Briefly, the ruffles were tracked starting around the time of the beginning of pronuclear appearance for an interval of 1000 seconds. The position of cortical ruffles was manually tracked and projected onto a calculated ellipse. One half of the ellipse was straightened to generate the xaxis, the anteroposterior axis. This procedure was done for each time point and laid down sequentially along the y-axis (time). Lines connect ruffles within nearest neighbor groups.
Tracking of PAR-2 and PAR-6 domain extent
The extent of the GFP-PAR-2 domain was manually tracked after the domain reached its maximal size. The extent of the GFP-PAR-6 domain was tracked after pseudocleavage regression. The domain size was calculated as a fraction of the respective embryo circumference. Manual tracking was performed using a custom-written macro (Stephan Grill) for NIH-Image (NIH). Further analysis was done with Mathematica 4.1 (Wolfram Research).
Kymograph analysis
Kymographs were done with Metamorph Software (Universal Imaging Corporation) from cortical YFP-CDC-42 time-lapse recordings (7-12 minutes total). Kymographs were made from a straight line along the long axis of the embryo.
Measurement of the position of the posterior boundary of YFP-CDC-42
Position was measured with Metamorph Software (Universal Imaging Corporation) as a distance along the long axis from the anterior pole. The distance was standardized to total embryo length (100%). 0% indicates the anterior (ANT) pole.
Tracking of NMY-2 foci
GFP-NMY-2 foci were manually tracked with Metamorph Software (Universal Imaging Corporation).
RESULTS
CDC-42 is required to remove PAR-2 from the cortex during meiosis
In wild-type embryos, after completion of meiosis, a polarizing signal from the centrosome leads to cortical PAR-2 localization at the posterior pole and the subsequent spreading of cortical PAR-2 over half of the embryo (Fig. 1 , see Movie 1 in the supplementary material) (Cowan and Hyman, 2004b; O'Connell et al., 2000) . Previous work has shown that in CDC-42-depleted embryos, PAR-2 was uniformly distributed throughout the cortex (Gotta et al., 2001; Kay and Hunter, 2001 ); however, the reason for this uniform distribution remained unclear. To investigate whether the uniform PAR-2 localization in cdc-42(RNAi) embryos is dependent on the centrosomal signal, CDC-42 was depleted together with SPD-2, a centrosomal protein essential for polarity establishment (Cowan and Hyman, 2004b; O'Connell et al., 2000) . In spd-2(RNAi);cdc-42(RNAi) embryos, GFP-PAR-2 localized uniformly at the cortex ( Fig. 2) , showing that the uniform PAR-2 distribution in cdc-42(RNAi) embryos is independent of the centrosome-dependent polarity signal. These data suggest that the aberrant PAR-2 distribution could be caused by an earlier defect in the PAR-2 localization mechanism. We next examined the meiotic cycle of GFP-PAR-2 in cdc-42(RNAi) embryos. We found that PAR-2 did not leave the cortex during meiosis II, but instead remained uniformly distributed throughout the cortex during the entire cell cycle (n=10, Fig. 1 ; data not shown). This data suggests that the defect in PAR-2 localization in cdc-42(RNAi) embryos results from a failure to remove PAR-2 from the cortex during the meiotic cycle. and Kemphues, 1999; Tabuse et al., 1998; Watts et al., 1996) . PAR-6 and CDC-42 physically interact in C. elegans and other systems (Gotta et al., 2001; Hutterer et al., 2004; Joberty et al., 2000; Johansson et al., 2000; Lin et al., 2000; Qiu et al., 2000) , and studies in C. elegans have suggested that CDC-42 is required to maintain PAR-6 in the anterior half (Gotta et al., 2001; Kay and Hunter, 2001) . We re-examined the requirement of CDC-42 for PAR-6 localization (Fig. 3A) . Because complete depletion of CDC-42 leads to sterility (data not shown), we determined the maximum depletion that would still yield embryos, and fixed and stained for PAR-6. Polarity formation can be divided into two phases: an establishment phase in which symmetry is broken and a PAR-6 domain is formed independently of PAR-2; and a maintenance phase, in which the maintenance of the PAR-6 domain in the anterior requires PAR-2 (Cuenca et al., 2003) . We found that in four out of four embryos examined during polarity establishment, PAR-6 was absent from the cortex. In four out of six embryos examined during the polarity maintenance phase, we also could not detect PAR-6 at the cortex (in two out of these six embryos, PAR-6 was weakly present in the anterior). This indicated that CDC-42 is required for localization of PAR-6 to the cortex during all stages of the mitotic cell cycle.
CDC-42 is required to localize PAR-6 to the cortex
The lack of cortical PAR-6 in cdc-42(RNAi) embryos could be directly due to CDC-42 depletion. This would be consistent with a previous result showing that PAR-6 binds to CDC-42 (Gotta et al., 2001) ; in addition the phenotypes of CDC-42 and PAR-6 depletion are similar. Alternatively, the aberrant localization of PAR-2 may prevent PAR-6 from localizing to the cortex. We attempted to distinguish between the two possibilities by performing double RNAi of cdc-42 and par-2 (Fig. 3A) . We found that PAR-6 can localize to the cortex after the reduction of both proteins, although at reduced levels relative to wild-type embryos (n=16/16). These data suggest that the aberrant PAR-2 localization may prevent PAR-6 from localizing to the cortex in cdc-42(RNAi) embryos, similar to recent work showing that mutant PAR-2 expressed ectopically in embryonic somatic blastomeres can displace PAR-3 from the cortex (Hao et al., 2006) . However, because we are not working under loss-of-function conditions for RNAi of CDC-42 (stronger RNAi conditions produce sterile worms), we cannot rule out the possibility that residual CDC-42 activity could directly recruit PAR-6 to the cortex after the removal of PAR-2. In support of this idea, the residual PAR-6 in the double RNAi embryos still localizes to the anterior cortex. Therefore, we conclude that a CDC-42-dependent activity is required to remove PAR-2 from the cortex and a CDC-42-dependent activity is necessary to localize PAR-6 to the cortex.
CDC-42 localizes to the anterior cortex
Because CDC-42 and PAR-6 form a complex (Gotta et al., 2001) , we hypothesized that the requirement of CDC-42 for PAR-6 localization may be reciprocal. To examine whether the anterior PAR proteins are required for CDC-42 localization, we generated a YFP-labeled CDC-42. The YFP-CDC-42 transgene rescues the loss of endogenous CDC-42 (see Materials and methods), suggesting that the fusion protein complements the function of endogenous CDC-42. YFP-CDC-42 formed dynamic structures at the cortex ( Fig. 4 ; see Movie 2 in the supplementary material) that segregated to the anterior cortex during polarity establishment (n=8), recapitulating the behavior of anterior PAR proteins (Cuenca et al., 2003; Munro et al., 2004) . Cortical YFP-CDC-42 disappeared around the time of pronuclear rotation (data not shown). To test whether the anterior PAR proteins are required for CDC-42 localization, we examined YFP-CDC-42 dynamics in the par-3(it71) loss-of-function mutant and in par-6(RNAi) embryos ( Fig. 4 ; Movie 3 in the supplementary material). We made kymographs from time-lapse recordings in control, mutant and RNAi embryos. In par-3(it71) (n=8) and par-6(RNAi) (n=7) embryos, CDC-42 segregated to the anterior, although segregation was slower than in control embryos (Fig. 4B) . Importantly, YFP-CDC-42 eventually localized in the anterior half as it did in control embryos.
Acto-myosin contractility is required to form an anterior cortical domain of CDC-42 CDC-42 segregation to the embryo anterior occurred coincident with the segregation of contractility. Therefore, we speculated that CDC-42 segregation might by regulated by the acto-myosin cytoskeleton. To test this idea, we followed the dynamics of CDC-42 distribution in embryos depleted of myosin II (NMY-2). We found that in nmy-2(RNAi) embryos, YFP-CDC-42 localized to the cortex, but did not segregate into an anterior domain (Fig. 4, n=5) . Thus, similar to the establishment of PAR polarity, the asymmetric distribution of CDC-42 requires acto-myosin activity.
RHO-1 is required for organization of the cortical myosin II network
During polarity establishment, acto-myosin contractility has to be temporally and spatially regulated such that contractile polarity is coordinated with other events in cell polarization. RhoA is a conserved regulator of acto-myosin contractility. Therefore, we investigated whether C. elegans RHO-1 and the putative RhoGEF ECT-2 regulate contractility during polarization. In all our experiments (see below), RNAi of ect-2 phenocopied the defects observed in rho-1(RNAi) embryos, but did not yield defects
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Development 133 (18) Fig. 2 . Meiotic GFP-PAR-2 localization is independent of the centrosomal signal. Embryos expressing GFP-PAR-2 were stained for GFP, SPD-2, microtubules (MT, green) and DNA (blue). In spd-2(RNAi) embryos, GFP-PAR-2 did not localize to the cortex. However, in cdc-42(RNAi);spd-2(RNAi) embryos, GFP-PAR-2 was found uniformly on the cortex as observed for cdc-42(RNAi) alone.
characteristic of CDC-42 depletion. This suggests that ECT-2 acts primarily on RHO-1 and not on CDC-42 during polarity establishment. Depletion of RHO-1 or ECT-2 abolished actin-dependent processes such as cortex ruffling and pseudocleavage furrow formation. Thus, contractile polarity was not established (Fig. 5) . The embryos also failed to extrude the polar bodies (data not shown) and cytokinesis failed, as has been previously shown (JantschPlunger et al., 2000) . These results suggest that depletion of RHO-1/ECT-2 disrupts the dynamics of the acto-myosin cytoskeleton.
To investigate the relationship between RHO-1 activity and cortical dynamics in more detail, we used a strain expressing NMY-2-GFP (Munro et al., 2004) to monitor myosin organization and dynamics in control and RNAi embryos (Fig. 6A) . In control embryos, NMY-2-GFP first forms a dynamic network throughout the entire cortex consisting of clustered foci interconnected by small filaments. At the onset of polarity, concomitant with the apposition of the centrosome at the posterior cortex, this network begins to disassemble in the vicinity of the nucleus/centrosome complex, and the remaining network segregates towards the anterior half (Munro et al., 2004 ) (see Movie 4 in the supplementary material). Reducing the function of either RHO-1 (n=10, data not shown) or ECT-2 (n=21) by RNAi altered the NMY-2-GFP organization ( Fig. 6A ; Movie 5 in the supplementary material). Specifically, the early network of interconnected foci clusters did not form. Instead, small foci were uniformly distributed throughout the cortex, reminiscent of the small foci that appear after polarity establishment in control embryos (Fig. 6A, t=750 seconds, 914 seconds). Despite these defects in myosin organization, we noticed that in ect-2(RNAi) (Fig. 6A, t=742 seconds, t=918 seconds) and rho-1(RNAi) (data not shown) embryos the small myosin foci collectively segregated into an anterior cap in a concerted direction at similar speeds (average velocity 0.17 m/second, n=10 foci in one embryo; Fig. 6C ). However, this cap was not stable (data not shown). In some ect-2(RNAi) embryos (six out of 21), the segregation occurred off the long embryo axis, as shown in Fig. 6A . This might reflect a failure in posteriorization (reviewed by Cowan and Hyman 2004a), but as little is known about the molecular details of posteriorization, we did not analyze this further. In four out of 21 ect-2(RNAi) embryos, NMY-2 segregation did not take place at any time. Similar results were found for embryos depleted of RHO-1 (data not shown).
The cdc-42(RNAi) embryos did not display any obvious structural alterations during the initial assembly of the NMY-2-GFP network (n=9; Fig. 6A , see also Movie 6 in the supplementary material). The contractile network formed and retracted towards the anterior to form a cap as in control embryos. However, the NMY-2-GFP cap was unstable. While the pseudocleavage furrow was regressing, small bright foci appeared and moved back towards the posterior (Fig. 6A, t=763 seconds, t=913 seconds) , implicating CDC-42 in stabilizing the acto-myosin network in the anterior half. Ruffle kymographs of cdc-42(RNAi) embryos revealed that the establishment of contractile polarity occurred, but the ruffles were more pronounced and less dynamic (Fig. 5) .
RHO-1 is required to form an anterior cortical domain of CDC-42
We have demonstrated above that the anterior cortical localization of CDC-42 depends on acto-myosin activity and that RHO-1 regulates the organization of the acto-myosin network. The 3511 RESEARCH ARTICLE CDC-42 and RHO-1 function in C. elegans polarity Fig. 3 . CDC-42 and RHO-1 are required for PAR-6 localization. (A) Embryos expressing GFP-PAR-2 were stained for GFP, PAR-6, microtubules (MT, green) and DNA (blue). In control embryos, PAR-6 localizes to the anterior pole, whereas PAR-2 localizes to the posterior pole. In cdc-42(RNAi) embryos, PAR-6 is not detectable at the cortex and PAR-2 is found at the entire cortex. In cdc-42(RNAi);par-2(RNAi) embryos, PAR-6 relocalizes anteriorly, but only at reduced levels. (B) Time-lapse images of GFP-PAR-6 polarity establishment in control and rho-1(RNAi) embryos. Times (seconds) are relative to nuclear envelope breakdown.
segregation of the acto-myosin network, however, could occur independently of RHO-1 activity. We therefore investigated whether CDC-42 segregation could occur in RHO-1-and ECT-2-depleted embryos.
In ect-2(RNAi) (n=6) and rho-1(RNAi) (n=5) embryos, YFP-CDC-42 remained localized over the whole cortex and did not segregate into an anterior domain ( Fig. 4 ; data not shown; see Movie 7 in the supplementary material). From this, we conclude that RHO-1 activity is essential for CDC-42 segregation to the anterior, but not its localization to the cortex. To test whether PAR-6 localization also requires RHO-1 activity, we made time-lapse movies of GFP-PAR-6 in rho-1(RNAi) and ect-2(RNAi) embryos. In all rho-1(RNAi) (n=6) and ect-2(RNAi) (n=11) one-cell embryos studied, GFP-PAR-6 remained localized throughout the cortex during the whole cell cycle and failed to segregate into an anterior domain ( Fig. 3B ; see Movies 8 and 9 in the supplementary material; data not shown). Thus, RHO-1 activity is also essential for the establishment of an anterior PAR-6 domain. Because CDC-42 distribution appears to dictate cortical PAR-6 localization, it is possible that the symmetric distribution of PAR-6 in rho-1(RNAi)/ect-2(RNAi) embryos reflects the defect in CDC-42 segregation. Interestingly, embryos depleted of RHO-1 (n=9/10, data not shown) or ECT-2 (Fig. 6A, n=17/21 ) sometimes segregated myosin to the anterior, whereas in all embryos studied under the same RNAi conditions, PAR-6 localization remained uniform n=63/63; n=6/6] . RHO-1 activity may therefore couple the anterior movement of myosin II with the anterior segregation of CDC-42 and PAR-6. In support of this idea, co-depletion of RHO-1 and CDC-42 resulted into an additive phenotype (see Fig. S1 in the supplementary material), from which we conclude that RHO-1 and CDC-42 function in separate pathways to localize the PAR proteins.
The coordination of anterior and posterior PAR polarity establishment requires RHO-1
The segregation of myosin II to the embryo anterior in rho-1(RNAi) (data not shown) and ect-2(RNAi) embryos (Fig. 6A) suggested that some aspects of polarity establishment can occur without the networklike organization of NMY-2, despite the failure to segregate CDC-42 and PAR-6 to the anterior. To determine whether the asymmetric distribution of PAR-2 was established in embryos depleted of RHO-1 activity, we analyzed whether the meiotic PAR-2 cycle is affected after depleting RHO-1. We found that the meiotic cycle is normal (n=6 ; Fig. 1C) ; however, we observed two classes of defects with respect to later PAR-2 localization in rho-1(RNAi) and ect-2(RNAi) embryos. In some embryos, PAR-2 did not localize to the cortex and appeared to remain in the cytoplasm [ect-2(RNAi), n=6/17; rho-1(RNAi), n=4/23; see Fig. S2 and Movie 10 in the supplementary material]. In the remaining embryos, PAR-2 localized to the cortex. However, the onset of the PAR-2 domain was late and its final size was enlarged [ect-2(RNAi), n=11/17; rho-1(RNAi), n=19/23; see Figs S2, S3 and Movie 11 in the supplementary material]. Different amounts of GFP-PAR-2 at the cortex could result from partial RHO-1 depletion. We then determined whether the establishment of PAR-2 polarity in embryos depleted of RHO-1 activity correlated with the segregation of NMY-2. Using a strain expressing both NMY-2-GFP and GFP-PAR-2, we found that NMY-2-GFP migration correlated with formation of the GFP-PAR-2 domain (n=19; Fig. 6B ). In embryos in which NMY-2 failed to segregate, we could not detect PAR-2 at the cortex (n=3; data not shown). As we never observed PAR-6 segregating into an anterior domain [ Fig. 3B , rho-1(RNAi), n=6 embryos; ect-2(RNAi), n=11 embryos (data not shown)], we concluded that when PAR-2 localizes to the cortex in the absence of RHO-1 activity, it must co-localize with PAR-6. We confirmed this by co-staining for PAR-2 and PAR-6 in ect-2(RNAi) embryos (see Fig. 
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Development 133 (18) S4 in the supplementary material). In all ect-2(RNAi) embryos analyzed, PAR-6 was uniformly localized (n=22/22). PAR-2 colocalized with PAR-6 in 17 out of 22 ect-2(RNAi) embryos. In five out of 22 ect-2(RNAi) embryos, PAR-2 did not localize to the cortex (data not shown). Therefore, we conclude that the formation of a PAR-2 domain is uncoupled from the establishment of the PAR-6 domain.
DISCUSSION
Our data show that RHO-1 and CDC-42 have distinct but coordinated functions in cell polarity in the first cell division of C. elegans. RHO-1 is required for the asymmetric distribution of CDC-42 during polarity establishment. CDC-42 is essential for localizing PAR-6 to the cortex during polarity establishment and for stabilizing the acto-myosin network.
After depleting RHO-1 activity, NMY-2 segregation is uncoupled from the anterior segregation of CDC-42 and PAR-6. Thus, the function of RHO-1 may be to couple the segregation of the actomyosin cytoskeleton to the segregation of the anterior PAR complex. Evidence for how RHO-1 might function in this regard comes from our analysis of the NMY-2 cytoskeleton. In control embryos, NMY-2 forms foci clusters interconnected by small filaments. In rho-1(RNAi) and ect-2(RNAi) embryos, the myosin foci are smaller and interconnections are not formed, but they can still segregate to the anterior (Fig. 6A) . We propose that RHO-1 links CDC-42 and PAR-6 with the segregation of the acto-myosin cortex by organizing the NMY-2 meshwork.
One interesting aspect of the rho-1(RNAi) phenotype is that the PAR-2 domain was often expanded, and, in extreme cases, uniformly distributed along the cortex (see Fig. S2 in the supplementary material). By contrast, PAR-6 was always uniformly localized (Fig. 3B) . Depletion of PAR-5 or proteins implicated in the regulation or formation of the cytoskeleton showed overlapping anterior and posterior PAR domains (Cuenca et al., 2003; Guo and Kemphues, 1996; Hill and Strome, 1990; Severson et al., 2002 ; Severson and Bowerman, 2003; Shelton et al., 1999) . However, an aberrant spreading of PAR-2 along the cortex leading, in some cases, to almost uniform PAR-2 distribution has not been observed previously. This implicates RHO-1 activity in the regulation of PAR-2 domain size and suggests that RHO-1-dependent acto-myosin contractility may also help to define the boundaries between anterior and posterior cortical domains in the embryo. One model of cortical polarity establishment suggests that the cortical acto-myosin network is under tension. A local break in the meshwork causes the meshwork to collapse away from the break point (Hird and White, 1993) , leaving the voided region of the cortex available for PAR-2 localization. RHO-1 activity might modulate the contractile forces within the network, resulting in an alteration of the boundary between the cytoskeleton network and the PAR-2 domain. We have shown that PAR-3 and PAR-6 are neither required to localize CDC-42 to the cortex nor essential for the segregation of CDC-42 to the anterior cortex. However, both proteins appear to be involved in regulating the velocity of the segregation of CDC-42 (Fig. 4B) . The segregation of CDC-42 depends on RHO-1 and NMY-2 activity (Fig. 4) , which correlates with previous findings that anterior PAR proteins have some regulatory function on the cytoskeleton (Munro et al., 2004) . Recent studies in MDCK II epithelial cells have also shown that PAR-3 modulates actin dynamics by regulating the Rac activity through the interaction with a Rac-specific GEF, Tiam1 (Chen and Macara, 2005) . So far, no evidence exists that Rac activity or a C. elegans homolog of Tiam1 is required for polarity establishment in one-cell embryos. However, it is possible that CDC-42 might regulate acto-myosin dynamics as part of a PAR-3/PAR-6/aPKC/CDC-42 complex. This idea is supported by studies that have shown that ECT-2 interacts with PAR-6 in a two hybrid assay (Liu et al., 2004) , and that PAR-3 inactivates cofilin by LIM kinase 2 (LIMK2), a downstream effector of the RHO-1 and CDC-42, which alters contractility in MDCK II cells (Chen and Macara, 2006) .
Our data indicate that a key function of CDC-42 during polarity establishment is to facilitate the localization of PAR-6 to the cortex. In the absence of CDC-42, PAR-6 is unable to localize to the cortex and PAR-2 is uniformly distributed along the cortex (Fig. 1, Fig.  3A ). This differs from previously published data, which suggested that CDC-42 was required to maintain PAR-6 in an anterior domain. However, in our study we obtained no evidence of PAR-6 localization to the anterior cortex after RNAi of CDC-42, either during the establishment or during the maintenance phase of polarity (Cuenca et al., 2003) . The most likely reason for this difference is that we are working under stronger RNAi conditions (see Materials and methods).
How might CDC-42 act to localize PAR-6? In other systems, CDC-42 binds to PAR-6 and activates its PDZ domain, enabling it to bind other partners. Thus, one likely possibility is that CDC-42 localizes to the cortex, where it in turn recruits PAR-6, triggering the assembly of the anterior PAR complex. In cdc-42(RNAi) embryos, PAR-2 stays localized uniformly over the cortex as the embryo enters mitosis. This is similar to the phenotype of par-6(RNAi), providing additional support for the idea that CDC-42 operates in concert with the anterior PAR complex. We show that this aberrant PAR-2 localization in cdc-42(RNAi) embryos excludes PAR-6 from localizing to the cortex (Fig. 3A) . In support of this idea, recent work has shown that ectopic mutant PAR-2 excludes PAR-3 from the apical cortex of embryonic somatic blastomeres (Hao et al., 2006) . Therefore, our data, and the findings of Hao et al. (Hao et al., 2006) , would support a model in which ectopic PAR-2 localization, in cdc-42(RNAi) embryos, is sufficient to displace PAR-6 from the cortex. However, it is unclear whether these two experimental situations rely on the same molecular machinery. Hao et al. (Hao et al., 2006) examined the ability of PAR-2 to displace PAR-3 from the cortex in cells that exhibit epithelial (apical-basal) polarity, and it has not been investigated whether localization of the anterior PAR complex in somatic blastomeres has the same molecular requirements, such as for CDC-42, as in one-cell embryos. Additionally, one important caveat in our experiments is that we are not working under full lossof-function conditions for cdc-42(RNAi) embryos (see Materials and methods) and, thus, we cannot rule out the possibility that residual CDC-42 in cdc-42(RNAi);par-2(RNAi) embryos can localize PAR-
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Development 133 (18) 6 after removal of PAR-2. Interestingly, PAR-6 is enriched in the anterior cortex in cdc-42(RNAi);par-2(RNAi) embryos. Because PAR-2 has been depleted, one might expect that PAR-6 would spread back to the posterior during the maintenance phase. This anterior enrichment of PAR-6 in cdc-42(RNAi);par-2(RNAi) embryos could suggest some partially counterbalancing antagonistic activities, as proposed by Gotta et al. (Gotta et al., 2001) . In wild-type embryos, PAR-2 does not prevent the localization of PAR-6 at the cortex during meiosis. PAR protein distribution changes from co-localization at meiosis to mutually exclusive domains at mitosis, which suggests that the distribution of PAR proteins is controlled differently during meiosis and mitosis. Thus, it is possible that the mechanism of PAR-6 localization to the cortex differs between the meiotic and mitotic cell cycle, and that cortical PAR-6 localization is CDC-42 independent during meiosis but CDC-42 dependent during mitosis. The cortical PAR-6 localization we observed in par-2(RNAi);cdc-42(RNAi) embryos would reflect the meiotic localization pathway. Ultimately, our experiments cannot distinguish between the varieties of models at this time. We conclude that CDC-42 has two activities: to remove PAR-2 from the cortex at the end of meiosis, and to localize PAR-6 throughout the cell cycle.
Taken together, our data suggest the following model: prior to polarity establishment, active RHO-1, perhaps regulated by ECT-2, organizes the acto-myosin into a contractile network. Both actin polymerization and NMY-2 activity contribute to the structure of the network and could be regulated by RHO-1. RHO-1-independent localization and/or activation of CDC-42 at the cortex triggers assembly of the anterior PAR complex. Upon perception of the centrosomal polarization signal, the myosin network, together with CDC-42 and the anterior PAR complex, segregates to the embryo anterior. This segregation is dependent on RHO-1 activity. At the same time, PAR-2 responds to the altered cortical structure resulting from the anterior segregation of myosin and establishes a posterior cortical domain.
